Humata Health vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $25M (Blue Venture Fund, Optum Ventures, Highmark Ventures). 225+ hospitals. ML recommends which clinical documents to include in prior auth submissions, reducing denials before submission.
About
Humata Health is a prior authorization AI platform serving the provider side of healthcare — helping hospital systems optimize their prior authorization submissions to reduce denial rates before claims are ever sent to payers. The company has raised $25 million from Blue Venture Fund, Optum Ventures, and Highmark Ventures, and is deployed at 225+ hospitals. Founded by an MD, the platform applies ML to recommend the specific clinical documentation that each payer's prior authorization algorithm weights most heavily.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.